Viking Therapeutics VKTX
NASDAQ VKTX
$25.83 -0.55 (-2.08%)
At close: Oct 22, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Selling, General & Administrative (2014 - 2026)

Updated

Viking Therapeutics (VKTX) reported Selling, General & Administrative of $16.84 million for Q2 2026, up 16.8% from $14.42 million a year earlier and up 20.5% from the prior quarter.

Analysis

Viking Therapeutics (VKTX) Selling, General & Administrative (2014 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Viking Therapeutics' Selling, General & Administrative came in at $50.71 million, down 11.8% year-over-year; for FY2025, it came in at $48.39 million, down 1.8% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 35.2% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $49.28 million in FY2024 (+33.1%), $37.02 million in FY2023 (+129.6%), $16.12 million in FY2022 (+50.6%) and $10.7 million in FY2021 (-0.3%).
  • The Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative in data going back to Q1 2014.
  • Year over year, Selling, General & Administrative gained in five of the last eight quarters, with growth averaging 20.3%.
  • The high point for year-over-year Selling, General & Administrative in five years was Q1 2023 (growth of 158.2%); the low point was Q3 2025 (a decline of 37.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $13.98 million (Q1 2026), $11.28 million (Q4 2025) and $8.61 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 6.29 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 3.63 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 5.65 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 1.92 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 3.41 Bn
10 Viking Therapeutics 3.01 Bn 488.21 Mn - 16.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.84 Mn
Mar 31, 2026 13.98 Mn
Dec 31, 2025 11.28 Mn
Sep 30, 2025 8.61 Mn
Jun 30, 2025 14.42 Mn
Mar 31, 2025 14.08 Mn
Dec 31, 2024 15.25 Mn
Sep 30, 2024 13.77 Mn
Jun 30, 2024 10.29 Mn
Mar 31, 2024 9.97 Mn
Dec 31, 2023 8.78 Mn
Sep 30, 2023 8.89 Mn
Jun 30, 2023 9.82 Mn
Mar 31, 2023 9.53 Mn
Dec 31, 2022 4.11 Mn
Sep 30, 2022 4.24 Mn
Jun 30, 2022 4.09 Mn
Mar 31, 2022 3.69 Mn
Dec 31, 2021 2.66 Mn
Sep 30, 2021 2.61 Mn
API Access

Viking Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VKTX&period=max&api_key=YOUR_API_KEY